|
Monday, February 28 — 8:00 AM — Convention Center Room 007 A-D
Click on the numbers in parentheses to display abstracts.
Section D - GYNECOLOGIC PATHOLOGY
Chaired by: John H. Eichhorn and C. Blake Gilks
| 8:00 |
Interobserver Variability of the Two-Tier System for Grading Ovarian Serous Carcinoma
(900)
A Malpica, MT Deavers, C Tornos, RJ Kurman, R Soslow, J Seidman, EN Atkinson, EG Silva - The UT M.D.Anderson Cancer Center, Houston, TX; Memorial Sloan Kettering Cancer Center, New York, NY; Johns Hopkins University, Baltimore, MD; Washington Hospital Center, Washington, DC
|
| 8:15 |
Survival Benefit for Patients with Advanced-Stage Transitional Cell Carcinomas vs. Other Subtypes of Ovarian Carcinoma after Chemotherapy with Platinum and Paclitaxel
(878)
F Kommoss, S Kommoss, D Schmidt, J Pfisterer, A du Bois - A2,2, Mannheim, Germany; Campus Kiel, Universitaetsklinikum Schleswig Holstein, Kiel, Germany; Dr.-Horst-Schmidt-Kliniken
(HSK), Wiesbaden, Germany
|
| 8:30 |
Classification of Extra-Ovarian Implants Associated with Ovarian Serous Tumors of Low Malignant Potential (S-LMP): Clinicopathologic Study of 181 Cases
(904)
JK McKenney, CB Gilks, TA Longacre - Stanford University, Stanford, CA; University of British Columbia, Vancouver, BC; UAMS, Little Rock, AR
|
| 8:45 |
The Recurrence Rate of Ovarian Serous Borderline Neoplasms with Noninvasive Implants Is Time Dependent
(947)
EG Silva, DM Gershenson, A Malpica, MT Deavers - M D Anderson; M D Anderson, Houston, TX
|
| 9:00 |
Histologic Patterns of Lymph Node Involvement in Women with Primary Ovarian Serous Tumors of Low Malignant Potential (S-LMP): A Clinicopathologic Study of 58 Cases
(903)
JK McKenney, BL Balzer, TA Longacre - Stanford University, Stanford, CA; UAMS, Little Rock, AR
|
| 9:15 |
Patterns of p53 Mutations Separate Ovarian Serous Borderline Tumors, Low and High-Grade Carcinomas and Provide Support for a New Model of Ovarian Carcinogenesis
(949)
G Singer, RJ Kurman, R Dehari, I-M Shih - Johns Hopkins Medical Institutions, Baltimore, MD
|
| 9:30 |
RECESS, EXHIBITS, POSTER SESSION I
|
| 11:00 |
Endocervical-Like Mucinous Borderline Tumors of the Ovary: A Clinicopathologic Analysis of 31 Cases
(933)
IM Rodriguez, JA Irving, J Prat - Hospital de la Santa Creu i Sant Pau. Autonomous University of Barcelona, Spain
|
| 11:15 |
Metastatic Colorectal Adenocarcinoma in the Ovary: Still a Diagnostic Challenge
(888)
MR Lewis, MT Deavers, EG Silva, A Malpica - M.D. Anderson Cancer Center, Houston, TX
|
| 11:30 |
Utility of Immunohistochemistry in Determining the Site of Origin of Metastatic Mucinous Carcinomas Involving the Ovary
(934)
B Ronnett, AM Gown, TS Barry, R Vang - Johns Hopkins Hospital, Baltimore, MD; PhenoPath Laboratories, Seattle, WA
|
| 11:45 |
Higher Frequencies of Chromosomal Aberrations in Ovarian Compared to Extragenital Endometriosis: A Possible Link to Endometrioid Adenocarcinoma
(882)
M Korner, E Burckhardt, L Mazzucchelli - University of Bern, Bern, Switzerland; Locarno, Switzerland
|
|
|
